Influence of Angiotensin-Converting-Enzyme Gene Polymorphism on Echocardiographic Data of Patients with Ischemic Heart Failure

Influence of Angiotensin-Converting-Enzyme Gene Polymorphism on Echocardiographic Data of Patients with Ischemic Heart Failure

Abstract Background: Association between angiotensin-converting-enzyme (ACE) gene polymorphisms and different clinical and echocardiographic outcomes has been described in patients with heart failure (HF) and coronary artery disease. Studying the genetic profile of the local population with both di...

Full description

Bibliographic Details
Main Authors:	Gustavo Salgado Duque, Dayse Aparecida da Silva, Felipe Neves de Albuquerque, Roberta Siuffo Schneider, Alinne Gimenez, Roberto Pozzan, Ricardo Mourilhe Rocha, Denilson Campos de Albuquerque
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Cardiologia (SBC)
Series:	Arquivos Brasileiros de Cardiologia
Subjects:	Heart Failure Polymorphism, Genetic Angiotensin-Converting Enzyme Inhibitors Echocardiography / methods
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2016005025102&lng=en&tlng=en

Similar Items

Angiotensin converting enzyme inhibitors /
by: DeBrue, Anne N.
Published: (c200)

Serum angiotensin converting enzyme in pemphigus vulgaris
by: Reza M Robati, et al.
Published: (2014-01-01)

Coenzyme Q10 Modulates Remodeling Possibly by Decreasing Angiotensin-Converting Enzyme in Patients with Acute Coronary Syndrome
by: Ram B. Singh, et al.
Published: (2018-07-01)

Antecedent Administration of Angiotensin‐Converting Enzyme Inhibitors or Angiotensin II Receptor Antagonists and Survival After Hospitalization for COVID‐19 Syndrome
by: Alberto Palazzuoli, et al.
Published: (2020-11-01)

Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis
by: Hyun Woo Lee, et al.
Published: (2021-03-01)

A continuous fluorescent assay for the determination of plasma and tissue angiotensin I-converting enzyme activity
by: M.F. Alves, et al.
Published: (2005-06-01)

Angiotensin-converting Enzyme Inhibitors: Can it be a Potential Treatment of Infantile Hemangioma
by: Archika Gupta, et al.
Published: (2021-01-01)

Postoperative angioedema induced by angiotensin-converting enzyme inhibitor: case report
by: Flora Margarida Barra Bisinotto, et al.
Published: (2019-12-01)

Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
by: Carlos P. Vio, et al.
Published: (2020-06-01)

Increased angiotensin-converting enzyme activity in the left ventricle after infarction
by: V.C.W. Busatto, et al.
Published: (1997-05-01)

Angiotensin-Converting Enzyme and Heart Failure
by: Sara Álvarez-Zaballos, et al.
Published: (2023-07-01)

Serum Neopterin and Angiotensin-converting Enzyme In Cancer Patients
by: Melichar Bohuslav, et al.
Published: (1994-11-01)

Structural determinants for binding to angiotensin converting enzyme 2 (ACE2) and angiotensin receptors
by: Daniel eClayton, et al.
Published: (2015-01-01)

A Rare Case of Unilateral Tongue Edema with Angiotensin Converting Enzyme Inhibitors
by: Beatriz Gil Braga, et al.
Published: (2022-07-01)

Progress of angiotensin converting enzyme 2 in cardiovascular diseases
by: JIAO Xiao-lu, QIN Yan-wen
Published: (2020-05-01)

Is there a difference between an angiotensin-converting enzyme inhibitor and an angiotensin-specific receptor blocker for the treatment of hypertension?
by: James A. Ker
Published: (2015-05-01)

Myocardial Angiotensin-Converting Enzyme 2 Protein Expression in Ischemic Heart Failure
by: Vitalija Siratavičiūtė, et al.
Published: (2023-12-01)

Hyperkalemia Associated with Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blockers in Chronic Kidney Disease
by: Yudi Her Oktaviono, et al.
Published: (2020-04-01)

Hyponatremia Induced by Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers-A Pilot Study
by: S Bhuvaneshwari, et al.
Published: (2018-07-01)

Relating angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers with incidence or mortality of COVID‐19
by: Martin C.S. Wong, et al.
Published: (2020-10-01)

Angiotensin-converting Enzyme Inhibitors-induced Angioedema
by: Chiriac Anca, et al.
Published: (2018-03-01)

Isolated Visceral Angioedema Induced by Angiotensin-Converting Enzyme Inhibitor
by: Ana Maria Oliveira, et al.
Published: (2016-05-01)

Stimulation of Angiotensin Converting Enzyme 2: A Novel Treatment Strategy for Diabetic Nephropathy
by: Haru Nomura, et al.
Published: (2022-01-01)

Angiotensin-Converting Enzyme Gene Insertion/Deletion Polymorphism and Its Association with the Severity of Preeclampsia
by: Özlem Banu Tulmaç, et al.
Published: (2011-12-01)

Association of Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With the Risk of Hospitalization and Death in Hypertensive Patients With COVID‐19
by: Rohan Khera, et al.
Published: (2021-07-01)

A Narrative Review on Nephrotic Syndrome Emphasizing its Correlation With Polymorphism of Angiotensin Converting Enzyme and Renin-Angiotensin System
by: Parisadat Ahmadi, et al.
Published: (2017-04-01)

Effect of angiotensin-converting enzyme inhibitors versus that of angiotensin receptor blockers on survival in patients undergoing hemodialysis: a nationwide observational cohort study
by: Seok Hui Kang, et al.
Published: (2024-12-01)

No harm from angiotensin-converting enzyme inhibitors or angiotensin receptor inhibitors in patients with COVID-19. Results of a prospective study on a hospital-based cohort
by: Gian Paolo Anzola, et al.
Published: (2020-09-01)

Tissue Angiotensin-Converting Enzyme in Patients With Various Clinical Forms of Psoriasis
by: Jasminko Huskić, et al.
Published: (2007-05-01)

A study of prognosis and outcome of COVID-19-infected hypertensive patients on angiotensin-converting enzyme inhibitors/angiotensin receptor blockers
by: M S Bharath, et al.
Published: (2024-01-01)

Decreased Plasma Levels of Angiotensin-Converting Enzyme Among Patients With Bipolar Disorder
by: Marsal Sanches, et al.
Published: (2021-02-01)

The role of renin-angiotensin system and angiotensin-converting enzyme 2 (ACE2) in the development and course of viral infection COVID-19 in patients with diabetes mellitus
by: O. K. Vikulova, et al.
Published: (2020-08-01)

Local Angiotensin-Converting Enzyme 2 Gene Expression in Kidney Allografts Is Not Affected by Renin-Angiotensin-Aldosterone Inhibitors
by: Monika Cahova, et al.
Published: (2021-03-01)

Medicinal chemistry of the renin-angiotensin system /
by: Timmermans, P. B. M. W. M., et al.
Published: (1994)

Gene polymorphisms of angiotensin-converting enzyme, angiotensin type 1 receptor and ⁪⁯α-adducin associated with renin angiotensin-aldosterone system in Malaysian end-stage renal disease patients
by: Ali, Aisyah
Published: (2012)

Stimulatory effect of dexamethasone on angiotensin-converting enzyme in neonatal rat cardiac myocytes
by: M.L.M. Barreto-Chaves, et al.
Published: (2000-06-01)

Management of hypertension in patients with COVID-19: Implication of angiotensin-converting enzyme 2
by: Guang-Hong Jia, et al.
Published: (2021-01-01)

Angiotensin-converting enzyme I/D polymorphism in chronic obstructive pulmonary disease
by: Pabst S, et al.
Published: (2009-12-01)

Effect of an angiotensin-converting-enzyme inhibitor on the plasma concentration of cytokines and vasoactive molecules in patients with coronary heart disease and hypertension
by: A A Khadartsev, et al.
Published: (2017-12-01)

Administration of Tranexamic Acid as Treatment for Angiotensin Converting Enzyme Inhibitor-Induced Angioedema: A Case Report
by: Sohun Awsare, et al.
Published: (2021-07-01)